Healthcare /
We are keen to invest in companies providing Healthcare Services to patients in the UK and France, but also look for opportunities to back producers of medical equipment and pharmaceuticals.
While the Healthcare Services sector presents some obvious risks and challenges, it is well suited to the Duke Street approach to company transformation. Many sectors are highly fragmented and ripe for consolidation – presenting huge scope for operational improvements and for organic and acquisition-led growth. In this context we are keen to back strong management teams to pursue these growth opportunities with a focus on quality and sector leadership.
We successfully demonstrated our approach with our investment in Paragon, the UK’s leading provider of care for residents with long-term learning difficulties. Currently we are backing four more management teams in this sector – Oasis, the UK dentistry group, Affinity, a leading regional provider of psychiatric care services, and Groupe Proclif, a fast-growing French private hospital group.
Although our recent investments have all been in healthcare services, we are also looking to invest in companies that manufacture and sell products, such as speciality pharmaceuticals, medical devices, backing strong management teams to pursue innovative growth strategies.
Total Duke Street investment in this sector
€942 million
"The market we operate in is a complex one. I have been very impressed with the level of sector knowledge displayed by the Investment team at Duke Street and the understanding and support given to us by our Operating Partner, John Robinson. We believe we have real opportunity to grow and to be recognised as a leader in the field."
Tommy MacDonald-Milner, CEO
Affinity Healthcare